As of 3:59pm ET
| +0.07 / +2.21%|
The 5 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 7.00, with a high estimate of 10.00 and a low estimate of 4.00. The median estimate represents a +116.05% increase from the last price of 3.24.
The current consensus among 5 polled investment analysts is to Hold stock in Celldex Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.